Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions.
about
The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation.Computational study on the origin of the cancer immunotherapeutic potential of B and T cell epitope peptides.An Altered Ratio of CD4+ And CD8+ T Lymphocytes in Cervical Cancer Tissues and Peripheral Blood – A Prognostic Clue?Expansion and Antitumor Cytotoxicity of T-Cells Are Augmented by Substrate-Bound CCL21 and Intercellular Adhesion Molecule 1.Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
P2860
Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions.
@en
type
label
Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions.
@en
prefLabel
Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions.
@en
P1433
P1476
Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions.
@en
P2093
Laszlo G Radvanyi
P304
P356
10.1097/PPO.0000000000000162
P577
2015-11-01T00:00:00Z